Haleon plc - ADR

Haleon plc - ADR

HLN

Market Cap$47.26B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Haleon plc - ADRHaleon plc - ADR66.62%9%11.10.6

Earnings Call Q2 2024

August 2, 2024 - AI Summary

Haleon reported a 1% growth in North America for the first half of 2024, with Q2 showing a decline due to inventory reductions and proactive measures taken regarding phenylephrine products.
The company expects the net sales growth in North America to improve in the second half as inventory reductions and other changes are factored into the base.
Organic sales growth in the second half is expected to be at least at the upper end of the 4% to 6% range, driven by strong performance in oral health and VMS categories.

Exclusive for Stockcircle Pro members

Sign upSign Up
$8.03

Current Fair Value

27.8% downside

Overvalued by 27.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$47.26 Billion
Enterprise Value$55.30 Billion
Dividend Yield$0.16 (1.99743892894348%)
Earnings per Share$0.11
Beta0.19
Outstanding Shares9,178,758,595

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio66.63
PEG-0.85
Price to Sales11.12
Price to Book Ratio11.12
Enterprise Value to Revenue4.92
Enterprise Value to EBIT22.68
Enterprise Value to Net Income38
Total Debt to Enterprise0.19
Debt to Equity0.64

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Haleon plc